3D-QSAR modeling and molecular docking studies on a series of 2, 4, 5-trisubstituted imidazole derivatives as CK2 inhibitors

References

• Akamatsu, M. (2002). Current state and perspectives of 3D-QSAR. Current Topics in Medicinal Chemistry, 2(12), 1381–1394. https://doi.org/10.2174/1568026023392887
   PubMedGoogle Scholar
• Awale, M., & Mohan, C. G. (2008). 3D-QSAR CoMFA analysis of C5 substituted pyrrolotriazines as HER2 (ErbB2) inhibitors. Journal of Molecular Graphics & Modelling, 26(7), 1169–1178. https://doi.org/10.1016/j.jmgm.2007.10.008
   PubMed Web of Science ®Google Scholar
• Brognard, J., & Hunter, T. (2011). Protein kinase signaling networks in cancer. Current Opinion in Genetics & Development, 21(1), 4–11. https://doi.org/10.1016/j.gde.2010.10.012
   PubMed Web of Science ®Google Scholar
• Buck, I. M., Black, J. W., Cooke, T., Dunstone, D. J., Gaffen, J. D., Griffin, E. P., Harper, E. A., Hull, R. A. D., Kalindjian, S. B., Lilley, E. J., Linney, I. D., Low, C. M. R., McDonald, I. M., Pether, M. J., Roberts, S. P., Shankley, N. P., Shaxted, M. E., Steel, K. I. M., Sykes, D. A., … Wright, P. T. (2005). Optimization of the in vitro and in vivo properties of a novel series of 2,4,5-trisubstituted imidazoles as potent cholecystokinin-2 (CCK2) antagonists. Journal of Medicinal Chemistry, 48(22), 6803–6812. https://doi.org/10.1021/jm0490686
   PubMed Web of Science ®Google Scholar
• Clark, M., Cramer, R. D., & Van, N. O. (1989). Validation of the general purpose tripos 5.2 force field. Journal of Computational Chemistry, 10(8), 982e1012–982e1012. https://doi.org/10.1002/jcc.540100804
   Web of Science ®Google Scholar
• El Aissouq, A., Toufik, H., Stitou, M., Ouammou, A., & Lamchouri, F. (2019). In silico design of novel tetra-substituted pyridinylimidazoles derivatives as c-jun N-terminal kinase-3 inhibitors, using 2D/3D-QSAR studies, molecular docking and ADMET prediction. International Journal of Peptide Research and Therapeutics. https://doi.org/10.1007/s10989-019-09939-8
   Google Scholar
• Fang, Y., Lu, Y., Zang, X., Wu, T., Qi, X., Pan, S., & Xu, X. (2016). Xu, 3D-QSAR and docking studies of flavonoids as potent Escherichia coli inhibitors. Scientific Reports, 6(1), 23634.
   PubMedGoogle Scholar
• Ferlay, B., Soerjomataram, J. I., Ervik, M., Dikshit, R., Eser, S., Mathers, C., Rebelo, M., Parkin, M., & Forman, D. M. (2013). Cancer incidence and mortality worldwide: IARC CancerBase. International Agency for Research on Cancer, 1, 39–55.
   Google Scholar
• Ferlay, J., Soerjomataram, I., Dikshit, R., Eser, S., Mathers, C., Rebelo, M., Parkin, D. M., Forman, D., & Bray, F. (2015). Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012. International Journal of Cancer, 136(5), E359–386. https://doi.org/10.1002/ijc.29210
   PubMed Web of Science ®Google Scholar
• Gagic, Z., Nikolic, K., Ivkovic, B., Filipic, S., & Agbaba, D. (2016). QSAR studies and design of new analogs of vitamin E with enhanced antiproliferative activity on MCF-breast cancer cells. Journal of the Taiwan Institute of Chemical Engineers, 59, 33–44. https://doi.org/10.1016/j.jtice.2015.07.019
   Web of Science ®Google Scholar
• Ganguly, S., & Banerjee, S. (2008). 3D-QSAR studies of imidazole derivatives as Candida albicans P450 - Demethylase inhibitors. Asian Journal of Chemistry, 20(6), 14.
   Google Scholar
• Goudzal, A., El Aissouq, A., & El Hamdani, H. (2020). QSAR modeling, molecular docking studies and ADMET prediction on a series of phenylaminopyrimidine-(thio) urea derivatives as CK2 inhibitors. Proceedings. https://doi.org/10.1016/j.matpr.2020.08.044.
   Google Scholar
• Jain, A. N. (2003). Surflex: Fully automatic flexible molecular docking using a molecular similarity-based search engine. Journal of Medicinal Chemistry, 46(4), 499–511.
   PubMed Web of Science ®Google Scholar
• Khan, M. S., Siddiqui, S. A., Siddiqui, M. S. R. A., Goswami, U., Srinivasan, K. V., & Khan, M. I. (2008). Antibacterial activity of synthesized 2,4,5-trisubstituted imidazole derivatives. Chemical Biology & Drug Design, 72(3), 197–204. https://doi.org/10.1111/j.1747-0285.2008.00691.x
   PubMed Web of Science ®Google Scholar
• Laufer, S. A., Striegel, H.-G., & Wagner, G. K. (2002). Imidazole inhibitors of cytokine release: Probing substituents in the 2 position. Journal of Medicinal Chemistry, 45(21), 4695–4705. https://doi.org/10.1021/jm020873z
   PubMed Web of Science ®Google Scholar
• Pandeya Nath, S. N. (2004). A text book of medicinal chemistry. SG Publisher, 1(3), 2–3.
   Google Scholar
• Peet, N. P. (2010). Drug resistance: A growing problem. Drug Discovery Today, 15(15–16), 583–586. https://doi.org/10.1016/j.drudis.2010.04.002
   PubMed Web of Science ®Google Scholar
• Pirhadi, S., & Ghasemi, J. B. (2010a). 3D-QSAR analysis of human immunodeficiency virus entry-1 inhibitors by CoMFA and CoMSIA. European Journal of Medicinal Chemistry, 45(11), 4897–4903. https://doi.org/10.1016/j.ejmech.2010.07.06.
   PubMed Web of Science ®Google Scholar
• Ramu, G., Kumar, G., Korra, R., Balaji, S., Dayakar, G., Palabindela, R., Myadaraveni, P., Reddy Yellu, N., & Kasula, M. (2017). EGFR, HER2 target based molecular docking analysis, in vitro screening of 2, 4, 5-trisubstituted imidazole derivatives as potential anti-oxidant and cytotoxic agents. Journal of Photochemistry & Photobiology, B: Biology, 176, 69–80. https://doi.org/10.1016/j.jphotobiol.2017.09.010 
   Google Scholar
• Rosemeyer, H. (2004) . https://en.m.wikipedia.org
   Google Scholar
• Sarno, S., Salvi, M., Battistutta, R., Zanotti, G., & Pinna, L. A. (2005). Features and potentials of ATP-site directed CK2 inhibitors. Biochimica et Biophysica Acta, 1754(1–2), 263–270. https://doi.org/10.1016/j.bbapap.2005.07.043
   PubMed Web of Science ®Google Scholar
• Search Results Web result with site links Gentside Découverte: Le magazine au coeur de notre planète. (n.d.). https://www.maxisciences.com
   Google Scholar
• Shalini, K., & Sharma, P. K., & Kumar, N. (2010). Imidazole and its biological activities: A review. Der Chemica Sinica, 1(3), 36–47.
   Google Scholar
• Sharma, G. V. M., Ramesh, A., Singh, A., Srikanth, G., Jayaram, A., Duscharla, D., Jun, J. H., Ummanni, R., & Malhotra, S. V. (2014). Imidazole derivatives show anticancer potential by inducing apoptosis and cellular senescence. MedChemCommun, 5(11), 1751–1760. https://doi.org/10.1039/C4MD00277F
   Web of Science ®Google Scholar
• Sprous, D. G., Palmer, R. K., Swanson, J. T., & Lawless, M. (2010). QSAR in the pharmaceutical research setting: QSAR models for broad, large problems. Current Topics in Medicinal Chemistry, 10(6), 619–637.
   PubMed Web of Science ®Google Scholar
• Tripos International, St. Louis, Missouri, 63144. (n.d.).
   Google Scholar
• Tropsha, A., & Golbraikh, A. (2007). Predictive QSAR modeling workflow, model applicability domains, and virtual screening. Current Pharmaceutical Design, 13(34), 3494–3504. https://doi.org/10.2174/138161207782794257
   PubMed Web of Science ®Google Scholar
• Tunkel, J., Mayo, K., Austin, C., Hickerson, A., & Howard, P. (2005). Practical considerations on the use of predictive models for regulatory purposes. Environmental Science & Technology, 39(7), 2188–2199. https://doi.org/10.1021/es049220t
   PubMed Web of Science ®Google Scholar
• Wei, S. P., Ji, Z. Q., Zhang, H. X., Zhang, J. W., Wang, Y. H., & Wu, W. J. (2011). Isolation, biological evaluation and 3D-QSAR studies of insecticidal/narcotic sesquiterpene polyol esters. Journal of Molecular Modeling, 17(4), 681–693.
   PubMed Web of Science ®Google Scholar
• Williams, D. A., & Lemke, T. L. (2002). Foye’s Principles of medicinal chemistry (Vol. 5, p. 36). Lippincott Williams and Wilkins.
   Google Scholar
• Xu, X., Wang, X., Li, Y., Wang, Y., & Yang, L. (2012). A large-scale association study for nanoparticle C60 uncovers mechanisms of nanotoxicity disrupting the native conformations of DNA/RNA. Nucleic Acids Research, 40(16), 7622–7632. https://doi.org/10.1093/nar/gks517
   PubMed Web of Science ®Google Scholar
• Zheng, J., Xiao, G., Guo, J., Zheng, Y., Gao, H., Zhao, S., Zhang, K., & Sun, P. (2011). Exploring QSARs for 5-lipoxygenase (5-LO) inhibitory activity of 2-substituted 5-hydroxyindole-3-carboxylates by CoMFA and CoMSIA. Chemical Biology & Drug Design, 78(2), 314–321. https://doi.org/10.1111/j.1747-0285.2011.01146.x
   PubMed Web of Science ®Google Scholar